4.4 Article

Pathology-preserving intensity standardization framework for multi-institutional FLAIR MRI datasets

期刊

MAGNETIC RESONANCE IMAGING
卷 62, 期 -, 页码 59-69

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.mri.2019.05.001

关键词

Brain; Fluid-attenuated inversion recovery; Intensity standardization; White matter lesions; Alzheimer's disease; Vascular disease; Segmentation

资金

  1. Natural Sciences and Engineering Research Council of Canada (NSERC)
  2. Canadian Institutes of Health Research Team Grant for Clinical Research Initiatives [CIHR- CRI 88057]
  3. Canada Foundation for Innovation [CFI CAIN 20099]
  4. government of Alberta
  5. government of Ontario
  6. government of Quebec
  7. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  8. DOD ADNI (Department of Defence) [W81XWH-12-2-0012]
  9. National Institute on Aging
  10. National Institute of Biomedical Imaging and Bioengineering
  11. AbbVie
  12. Alzheimer's Association
  13. Alzheimer's Drug Discovery Foundation
  14. Araclon Biotech
  15. BioClinica, Inc.
  16. Biogen
  17. Bristol-Myers Squibb Company
  18. CereSpir, Inc.
  19. Cogstate
  20. Eisai Inc.
  21. Elan Pharmaceuticals, Inc.
  22. Eli Lilly and Company
  23. Eurolmmun
  24. F. Hoffmann-La Roche Ltd.
  25. Genentech, Inc.
  26. Fujirebio
  27. GE Healthcare
  28. IXICO Ltd.
  29. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  30. Johnson & Johnson Pharmaceutical Research & Development LLC.
  31. Lumosity
  32. Lundbeck
  33. Merck Co., Inc.
  34. Meso Scale Diagnostics, LLC.
  35. NeuroRx Research
  36. Novartis Pharmaceuticals Corporation
  37. Pfizer Inc.
  38. Piramal Imaging
  39. Servier
  40. Takeda Pharmaceutical Company
  41. Transition Therapeutics
  42. Canadian Institutes of Health Research
  43. Neurotrack Technologies

向作者/读者索取更多资源

Fluid-Attenuated Inversion Recovery (FLAIR) MRI are used by physicians to analyze white matter lesions (WML) of the brain, which are related to neurodegenerative diseases such as dementia and vascular disease. To study the causes and progression of these diseases, multi-centre (MC) studies are conducted, with images acquired and analyzed from multiple institutions. Due to differences in acquisition software and hardware, there is variability in image properties, which creates challenges for automated algorithms. This work explores this variability, known as the MC effect, by analyzing nearly 5000 MC FLAIR volumes and proposes an intensity standardization framework to normalize intensity non-standardness in FLAIR MRI, while ensuring the appearance of WML. Results show that original image characteristics varied significantly between scanner vendors and centres, and that this variability was reduced with standardization. To further highlight the utility of intensity standardization, a threshold-based brain extraction algorithm is implemented and compared with a classifier-based approach. A competitive Dice Similarity Coefficient of 81% was achieved on 183 volumes, demonstrating that optimized pre-processing can effectively reduce the variability in MC studies, allowing for simplified algorithms to be applied on large datasets robustly.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据